Replies to post #5198 on Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

It seems like I have noticed a slight change on LinkedIn. Everyone associated with the Ophthalmics division seems to have updated their profiles to "Verséa Health" instead of "Verséa Ophthalmics".

Could be nothing.
Maybe just streamlined messaging for advertising purposes.

Just a curious little change. Plus the Verséa Ophthalmics LinkedIn page has been unusually quiet.

I'm okay to be wrong.

[TexasMarvL]

How is a public company taken private?

What would our shares be worth if AXIM management agreed to a merger to take AXIM private?

I don't know.
I'm asking the questions.

This would probably not be a good thing for retail investors. I guess it could happen if our management wanted it to happen.

[TexasMarvL]

Just a guess but I bet Verséa Health's covid19 test business is shrinking to nothing.

Verséa Ophthalmics is still not generating enough cash-flow. I just think AXIM and Verséa Ophthalmics need an infusion of investment for the next stage of growth.

Maybe the new AS/OS is delayed because of a pending merger??

I don't know.

When there is no news to report I guess I tend to fill the void with opinions.

[TexasMarvL]

I guess the worst-case scenario is Verséa Ophthalmics is insolvent and Verséa Health needs to cut that division.

Without CLIA waiver approvals Verséa Ophthalmics and AXIM are both burning a lot of cash. Adding just one paying customer a week seems like it will take too long to be cash-flow positive.

In that case maybe Mr Huemoeller does change gears and try to market the TPOC Tear-based Point-of-Care Parkinson Disease test.

I guess anything is possible at this point.

I guess we will know soon enough.

Good luck to all.
Not investment advice.